Skip to main content

Table 5 Cox multivariate analysis of disease-free and overall survival by molecular subtypes

From: Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series

 

Recur

P-value

Death

P-value

 

HR (95% CI)

 

HR (95% CI)

 

Luminal A

    

Mode of BC Detection

    

Screen Detected

1.00

 

1.00

 

Symptomatic

2.73 (1.05–7.13)

.03

4.2 (0.97–18.16)

.05

Tumor size

 

.91

 

.72

T1

1.00

 

1.00

 

T2

1.11 (0.56–2.2)

.73

1.19 (0.51–2.78)

.74

T3–T4

1.09 (0.42–2.87)

.81

0.69 (0.18–2.58)

.52

No. of positive Lymph nodes

 

<.0001

 

<.0001

All lymph nodes negative

1.00

 

1.00

 

1–3

1.9 (0.81–4.47)

.12

2.84 (0.89–9.05)

.07

≥4

6.27 (3.05–12.91)

<.0001

9.69 (3.57–26.26)

<.0001

Luminal B

    

Mode of BC Detection

    

Screen Detected

1.00

 

1.00

 

Symptomatic

2.66 (0.59–11.88)

.21

2.79 (0.33–23.7)

.33

Tumor size

 

.4

 

.05

T1

1.00

 

1.00

 

T2

1.05 (0.39–2.77)

.91

0.56 (0.11–2.92)

.53

T3–T4

2.61 (0.58–11.71)

.22

5.59 (1.03–30.22)

.04

No. of positive Lymph nodes

 

.12

 

.74

All lymph nodes negative

1.00

 

1.00

 

1–3

2.55 (0.82–7.88)

.01

0.81 (0.14–4.52)

.81

≥4

3.55 (1.02–12.42)

.04

1.66 (0.35–7.75)

.52

Non Luminal Her2+

    

Mode of BC Detection

    

Screen Detected

1.00

 

1.00

 

Symptomatic

1.86 (0.19–18.18)

.72

1.43 (0.14–14.05)

.91

Tumor size

 

.03

 

.09

T1

1.00

 

1.00

 

T2

1.77 (0.47–6.67)

.44

5.48 (1.02–29.2)

.05

T3–T4

8.62 (1.65–44.78)

.01

8.56 (1.05–69.9)

.04

No. of positive Lymph nodes

 

.81

 

.42

All lymph nodes negative

1.00

 

1.00

 

1–3

1.47 (0.38–5.6)

.84

0.41 (0.09–1.88)

.22

≥4

1.54 (0.34–7.05)

.51

1.07 (0.22–5.1)

.91

Triple Negative

    

Mode of BC Detection

    

Screen Detected

1.00

 

1.00

 

Symptomatic

0.14 (0.008–2.39)

.11

n.e*.

 

Tumor size

 

.11

 

.12

T1

1.00

 

1.00

 

≥T2

7.17 (1.15–44.72)

.03

7.41 (0.61–89.8)

.14

No. of positive Lymph nodes

 

.001

 

.01

All lymph nodes negative

1.00

 

1.00

 

All lymph nodes positive

3.58 (3.65–7.76)

.001

4.85 (1.46–16.13)

.01

  1. *n.e. not evaluable.